Marburg Facility

Located in the heart of Europe, our Marburg laboratory maintains a staff of approximately 90 employees in a 25,000 square foot space. The facility operates under BSL-2 and BSL-3, with an additional 750 sq. ft. dedicated to the handling of genetically modified organisms.

Download Site Information Sheet

With more than 20 years of demonstrated expertise in selecting, developing, and validating immunological assays in support of vaccine development, we provide cutting-edge expertise on tailored functional and immuno-binding serological assays for vaccine licensures.

We operate under GCLP using fit-for-purpose quality systems with a track record of success in authority lab inspections.

Equipment and Techniques

The following is a list of equipment and techniques performed on our infectious disease platform within our laboratory operations at our Marburg location.

• Microtechnix Scanlab II
• Synbiosis ProtoCOL
• Luminex^® FLEXMAP 3D
• Molecular Devices SpectraMax i3x
• Tecan Infinite 200 Pro Plate Reader
• BioTek Microtiter Plate
• Reader & Washer
• Scinomix Tube Labeler
• Tecan Liquid Handler &  Robotic Units (EVO 75,100,200)
• Thermo Fisher Scientific KingFisher Duo Prime
• Deep Freezer Capacity (-80°C & Liquid Nitrogen)
• Clean Benchmark 

State-of-the-Art Facilities

Our state-of-the-art facility design promotes scientific excellence through our team of scientists, highly automated workflows, and data management through Laboratory Information Management System (LIMS) systems to support client studies whether they are research based or require fully validated systems as per required standards, including 21 CFR Part 11 compliance. Documentation is preserved in internal and external archives with restricted access to safeguard data and study materials throughout the retention period.

Quality Management System

Our well-defined quality management system (QMS) seamlessly aligns with regulatory requirements GCLP and GCP standards ensure compliance for our clients and for the studies we support. 

Current Accreditations/Certifications

• GCLP (Vaccines)
• GLP (Beijing)
• AAALAC — Association for Assessment and Accreditation of Laboratory Animal Care (Preclinical Laval and Beijing) 

• CCAC — Canadian Council on Animal Care (Preclinical)
• OLAW — Office of Laboratory Animal Welfare (Preclinical)
• BBL — Belgian Banking License (Gosselies)

Robust Data and Scientific Processes

We support your preclinical and clinical molecule/vaccine candidate development — with data and study sample testing managed by our validated, customized, LIMS and its full audit trail.

Sample Management

Our team provides the same uncompromising attention to detail whether you have 10 samples or a million. Each analytical and data plan is custom crafted to ensure we meet all deliverables for all stakeholders. Customized reporting delivers the specific data results you want, on the schedule you require.

Integrated Approach

IQVIA Laboratories Vaccines global scale and high-volume capabilities combines our high-touch, individualized service with the capacity and global coverage to move even the largest projects forward on time and on budget. All while adhering to regulatory requirements including chain of custody, IATA (International Air Transport Association) shipping guidelines, and sample verification upon receipt. We also provide both long- and short-term sample storage. Our fully integrated approach streamlines the management and handling of your data throughout the sample life cycle, resulting in accurate, actionable, and timely evidence.